Your browser doesn't support javascript.
loading
ERINA Is an Estrogen-Responsive LncRNA That Drives Breast Cancer through the E2F1/RB1 Pathway.
Fang, Zihui; Wang, Yue; Wang, Zehua; Xu, Meishu; Ren, Songrong; Yang, Da; Hong, Mei; Xie, Wen.
Afiliação
  • Fang Z; Center for Pharmacogenetics and Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Wang Y; College of Life Sciences, South China Agricultural University, Guangzhou, China.
  • Wang Z; Center for Pharmacogenetics and Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Xu M; Center for Pharmacogenetics and Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Ren S; Center for Pharmacogenetics and Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Yang D; Center for Pharmacogenetics and Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Hong M; Center for Pharmacogenetics and Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Xie W; College of Life Sciences, South China Agricultural University, Guangzhou, China. mh2788@scau.edu.cn wex6@pitt.edu.
Cancer Res ; 80(20): 4399-4413, 2020 10 15.
Article em En | MEDLINE | ID: mdl-32826278

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Ubiquitina-Proteína Ligases / Fator de Transcrição E2F1 / Proteínas de Ligação a Retinoblastoma / RNA Longo não Codificante Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Cancer Res Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Ubiquitina-Proteína Ligases / Fator de Transcrição E2F1 / Proteínas de Ligação a Retinoblastoma / RNA Longo não Codificante Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Cancer Res Ano de publicação: 2020 Tipo de documento: Article